How big is the Netherlands Pharmaceutical Market?

The Netherlands Pharmaceutical Market size is expected to reach USD 9.92 billion in 2024 and grow at a CAGR of 7.5% to reach USD 14.24 billion by 2029. Read More

What is the current Netherlands Pharmaceutical Market size?

In 2024, the Netherlands Pharmaceutical Market size is expected to reach USD 9.92 billion. Read More

Who are the key players in Netherlands Pharmaceutical Market?

Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Novartis AG and F. Hoffmann-La Roche AG are the major companies operating in the Netherlands Pharmaceutical Market. Read More

What years does this Netherlands Pharmaceutical Market cover, and what was the market size in 2023?

In 2023, the Netherlands Pharmaceutical Market size was estimated at USD 9.18 billion. The report covers the Netherlands Pharmaceutical Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Netherlands Pharmaceutical Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Netherlands Pharmaceutical Industry Analysis | Market Growth, Size & Forecast Report

Netherlands Pharmaceutical Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Pharmaceutical Companies in Netherlands and the Market is Segmented by ATC/Therapeutic Class (Alimentary Tract and Metabolism, Blood and Blood-Forming Organs, Cardiovascular System, Dermatological Drugs, Genitourinary System and Reproductive Hormones, Systemic Hormonal Preparations, Excluding Reproductive Hormones and Insulins, Anti Infectives for Systemic Use, Antineoplastic and Immunomodulating Agents, Musculoskeletal System, Nervous System, Antiparasitic Products, Insecticides and Repellents, Respiratory System, Sensory Organs, and Various ATC Structure), and Mode of Dispensing (Prescription and OTC).

Netherlands Pharmaceutical Industry Overview

The Dutch pharmaceutical market is moderately fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some of the key companies which are currently dominating the market are Abbott Laboratories, AbbVie Inc., Amgen Inc., Astellas Pharma, AstraZeneca PLC, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co., Novartis AG, and Pfizer Inc.